Vascular Grafts Market Growth, Size, Trends, Report 2023-2028

Posted by

How big is the Global Vascular Grafts Market?

IMARC Group, a leading market research company, has recently releases report titled “Vascular Grafts Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global vascular graft market growth, share, size, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

The global vascular graft market size reached US$ 1.79 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.57 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028.

What are Vascular Grafts?

Vascular grafts are medical implants or conduits that replace, repair, and bypass damaged or diseased blood vessels within the human circulatory system. They are available in various sizes, shapes, and materials to meet specific patient needs. They enable the restoration of blood circulation to vital organs, limbs, or tissues compromised by blocked and damaged vessels. They can alleviate symptoms and improve the quality of life in patients with conditions like aneurysms and peripheral arterial disease. They can be tailored to match the specific anatomical and physiological requirements of the patient. They are widely used in life-saving procedures such as coronary artery bypass grafting (CABG) for heart disease and peripheral bypass grafts for limb salvage. Besides this, they are utilized in research settings to study and develop new treatments for vascular diseases and disorders.

Request a Free PDF Sample for more detailed market insights: 

Report Highlights

Report Attributes Details
Market Size in 2022 US$ 1.8 Billion
Market Forecast in 2028 US$ 2.6 Billion
Growth rate (2023 to 2028) CAGR of 6.1%
Base Year of the Analysis 2022
Forecast Period 2023-2028

What are the growth prospects and trends in the Vascular Grafts industry?

The increasing prevalence of atherosclerosis, aneurysms, and peripheral arterial disease due to several factors, such as aging populations and lifestyle choices, represents one of the primary factors catalyzing the demand for vascular grafts. Apart from this, continuous technological advancements and innovations in vascular surgery techniques are propelling the market growth. Along with this, the rising preferences of individuals for minimally invasive procedures, endovascular practices, and robotic-assisted surgeries are offering a favorable market outlook. Moreover, the governing authorities of several countries and healthcare organizations are recognizing the importance of addressing vascular diseases. They are undertaking various initiatives and funding for research in the industry, which is strengthening the growth of the market. Besides this, the rising collaborations between medical device companies, research institutions, and healthcare providers are accelerating innovation in the vascular grafts sector. These partnerships foster the development of cutting-edge graft materials, designs, and surgical. In addition, the rising trend of customization is propelling the market growth. Grafts are increasingly customized to meet the specific anatomical and physiological requirements of individual patients.

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Abbott Laboratories
  • B. Braun SE (B. Braun Holding GmbH & Co. KG)
  • Becton
  • Dickinson and Company
  • Cook Group Incorporated
  • Cordis
  • CryoLife Inc.
  • Getinge AB
  • Heat Medical Europe BV
  • LeMaitre Vascular
  • Medtronic plc
  • Terumo Corporation
  • W. L. Gore & Associates Inc.

What is included in market segmentation?

Breakup by Product:

  • Endovascular Stent Grafts
  • Hemodialysis Access Grafts
  • Coronary Artery By-Pass Grafts
  • Vascular Grafts for Aorta Disease
  • Peripheral Vascular Grafts

Breakup by Raw Material:

  • Polytetrafluoroethylene (PTFE)
  • Polyester
  • Polyurethane
  • Biosynthetic

Breakup by Application:

  • Cardiac Aneurysm
  • Kidney Failure
  • Vascular Occlusion
  • Coronary Artery Disease

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Key highlights of the report:
• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US


134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800


Follow us on Twitter: @imarcglobal


Leave a Reply

Your email address will not be published. Required fields are marked *